Furthermore, we found invariably positive correlations between CD8A expression and CTL levels of patients in these cohorts, such observations corroborated the established role of CD8A in promoting CTL-mediated tumor killing (Oja et al., 2018; Krishna et al., 2021). The gene discussed is CD8A; the disease is neoplasm.